These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26301813)

  • 21. Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype.
    Han Z; Banworth MJ; Makkia R; Conley SM; Al-Ubaidi MR; Cooper MJ; Naash MI
    FASEB J; 2015 Jun; 29(6):2535-44. PubMed ID: 25713057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early therapeutic trials for retinitis pigmentosa].
    Dufier JL
    Bull Acad Natl Med; 2003; 187(9):1685-92; discussion 1692-4. PubMed ID: 15369238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.
    Bemelmans AP; Kostic C; Crippa SV; Hauswirth WW; Lem J; Munier FL; Seeliger MW; Wenzel A; Arsenijevic Y
    PLoS Med; 2006 Oct; 3(10):e347. PubMed ID: 17032058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lentivirus-mediated expression of cDNA and shRNA slows degeneration in retinitis pigmentosa.
    Tosi J; Sancho-Pelluz J; Davis RJ; Hsu CW; Wolpert KV; Sengillo JD; Lin CS; Tsang SH
    Exp Biol Med (Maywood); 2011 Oct; 236(10):1211-7. PubMed ID: 21885480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal models and different therapies for treatment of retinitis pigmentosa.
    Rivas MA; Vecino E
    Histol Histopathol; 2009 Oct; 24(10):1295-322. PubMed ID: 19688697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping retinal degeneration and loss-of-function in Rd-FTL mice.
    Greferath U; Goh HC; Chua PY; Astrand E; O'Brien EE; Fletcher EL; Murphy M
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5955-64. PubMed ID: 19661224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambient hypoxia reverses retinal vascular attenuation in a transgenic mouse model of autosomal dominant retinitis pigmentosa.
    Penn JS; Li S; Naash MI
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):4007-13. PubMed ID: 11053306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa.
    Komeima K; Rogers BS; Campochiaro PA
    J Cell Physiol; 2007 Dec; 213(3):809-15. PubMed ID: 17520694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Retinitis pigmentosa: eye sight restoration by optogenetic therapy].
    Roska B; Busskamp V; Sahel JA; Picaud S
    Biol Aujourdhui; 2013; 207(2):109-21. PubMed ID: 24103341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microglia modulation by TGF-β1 protects cones in mouse models of retinal degeneration.
    Wang SK; Xue Y; Cepko CL
    J Clin Invest; 2020 Aug; 130(8):4360-4369. PubMed ID: 32352930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.
    Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J
    Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in treatment of retinitis pigmentosa.
    He Y; Zhang Y; Su G
    Curr Stem Cell Res Ther; 2015; 10(3):258-65. PubMed ID: 25345673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A frameshift mutation in RPGR exon ORF15 causes photoreceptor degeneration and inner retina remodeling in a model of X-linked retinitis pigmentosa.
    Beltran WA; Hammond P; Acland GM; Aguirre GD
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1669-81. PubMed ID: 16565408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinitis pigmentosa: impact of different Pde6a point mutations on the disease phenotype.
    Sothilingam V; Garcia Garrido M; Jiao K; Buena-Atienza E; Sahaboglu A; Trifunović D; Balendran S; Koepfli T; Mühlfriedel R; Schön C; Biel M; Heckmann A; Beck SC; Michalakis S; Wissinger B; Seeliger MW; Paquet-Durand F
    Hum Mol Genet; 2015 Oct; 24(19):5486-99. PubMed ID: 26188004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Rescue Reverses Microglial Activation in Preclinical Models of Retinitis Pigmentosa.
    Zhang L; Cui X; Jauregui R; Park KS; Justus S; Tsai YT; Duong JK; Hsu CW; Wu WH; Xu CL; Lin CS; Tsang SH
    Mol Ther; 2018 Aug; 26(8):1953-1964. PubMed ID: 30001913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of cone molecular markers in rhodopsin-mutant human retinas with retinitis pigmentosa.
    John SK; Smith JE; Aguirre GD; Milam AH
    Mol Vis; 2000 Nov; 6():204-15. PubMed ID: 11063754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy into photoreceptors and Müller glial cells restores retinal structure and function in CRB1 retinitis pigmentosa mouse models.
    Pellissier LP; Quinn PM; Alves CH; Vos RM; Klooster J; Flannery JG; Heimel JA; Wijnholds J
    Hum Mol Genet; 2015 Jun; 24(11):3104-18. PubMed ID: 25701872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synthetic progestin norgestrel acts to increase LIF levels in the rd10 mouse model of retinitis pigmentosa.
    Byrne AM; Roche SL; Ruiz-Lopez AM; Jackson AC; Cotter TG
    Mol Vis; 2016; 22():264-74. PubMed ID: 27081297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy.
    Ali RR; Sarra GM; Stephens C; Alwis MD; Bainbridge JW; Munro PM; Fauser S; Reichel MB; Kinnon C; Hunt DM; Bhattacharya SS; Thrasher AJ
    Nat Genet; 2000 Jul; 25(3):306-10. PubMed ID: 10888879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.